![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
CS Bockman, WB Jeffries and PW Abel
Department of Pharmacology, Creighton University School of Medicine, Omaha, Nebraska.
Alpha-2 adrenergic receptor subtypes were characterized in membranes of pig vascular endothelium using [3H]rauwolscine. Alpha-2 adrenergic receptor subtypes that mediate endothelium-dependent vascular relaxation were studied in vitro by using ring segments of pig epicardial coronary arteries. Specific [3H]rauwolscine binding in endothelial membranes was saturable and to a single class of high- affinity sites with a mean KD of 0.217 +/- 0.05 nM and Bmax of 156 +/- 28 fmol/mg of protein. Nonlinear regression analysis indicated that competition binding curves for drugs that distinguish the alpha-2A adrenergic receptor subtype from the alpha-2C adrenergic receptor subtype fit best to two-site binding models. Kl values for drugs in binding to endothelial alpha-2 adrenergic receptors correlated well with their Kl values for alpha-2A (r = .98) and alpha-2C (r = .97) adrenergic receptor subtypes identified in other tissues. Vascular endothelium contained 23% alpha-2A and 77% alpha-2C adrenergic receptors. In the presence of indomethacin, the rank order of potency for agonists that cause endothelium-dependent vascular relaxation was p- iodoclonidine > clonidine > UK-14,304 > guanabenz > epinephrine > norepinephrine. KB values for antagonist inhibition of epinephrine- induced, endothelium-dependent vascular relaxation correlated best with Kl values for antagonist binding at the alpha-2A adrenergic receptor subtype. These results suggest that the alpha-2A and alpha-2C adrenergic receptor subtypes are present on pig vascular endothelium and that the alpha-2A adrenergic receptor subtype mediates indomethacin- insensitive, endothelium-dependent relaxation of pig epicardial coronary arteries.
This article has been cited by other articles:
|
|
 |
|
  R. H. Rosa Jr., T. W. Hein, Z. Yuan, W. Xu, M. I. Pechal, R. L. Geraets, J. M. Newman, and L. Kuo Brimonidine evokes heterogeneous vasomotor response of retinal arterioles: diminished nitric oxide-mediated vasodilation when size goes small Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H231 - H238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hermann, T. Schlereth, T. Vogt, and F. Birklein Clonidine induces nitric oxide- and prostaglandin-mediated vasodilation in healthy human skin J Appl Physiol, December 1, 2005; 99(6): 2266 - 2270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Striimper, M. Durieux, and P. Roekaerts Endothelial and Microvascular Function Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2003; 7(3): 225 - 238. [Abstract] [PDF]
|
|
|
|
 |
|
 C. F. Plato and J. L. Garvin alpha 2-Adrenergic-mediated tubular NO production inhibits thick ascending limb chloride absorption Am J Physiol Renal Physiol, October 1, 2001; 281(4): F679 - F686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Tuttle and J. C. Falcone Nitric oxide release during {alpha}1-adrenoceptor-mediated constriction of arterioles Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H873 - H881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Guimaraes and D. Moura Vascular Adrenoceptors: An Update Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. J. Waugh, C. S. Bockman, D. D. Smith, and P. W. Abel Limitations in Using Peptide Drugs to Characterize Calcitonin Gene-Related Peptide Receptors J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1419 - 1426. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Lachkar, C. Migdal, and S. Dhanjil Effect of Brimonidine Tartrate on Ocular Hemodynamic Measurements Arch Ophthalmol, December 1, 1998; 116(12): 1591 - 1594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. D. Callow, P. Campisi, M. L. Lambert, Q. Feng, and J. M. O. Arnold Enhanced in vivo alpha 1- and alpha 2-adrenoceptor-mediated venoconstriction with indomethacin in humans Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H837 - H843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Thorin, P. L. Huang, M. C. Fishman, and J. A. Bevan Nitric Oxide Inhibits {alpha}2-Adrenoceptor–Mediated Endothelium-Dependent Vasodilation Circ. Res., June 29, 1998; 82(12): 1323 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Thorin, P. Cernacek, and J. Dupuis Endothelin-1 Regulates Tone of Isolated Small Arteries in the Rat : Effect of Hyperendothelinemia Hypertension, April 1, 1998; 31(4): 1035 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Thorin, T.-D. Nguyen, A. Bouthillier, and F. M. Faraci Control of Vascular Tone by Endogenous Endothelin-1 in Human Pial Arteries • Editorial Comment Stroke, January 1, 1998; 29(1): 175 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Nase and M. A. Boegehold Postjunctional alpha 2-adrenoceptors are not present in proximal arterioles of rat intestine Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H202 - H208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Thorin, S. M. Shreeve, N. Thorin-Trescases, and J. A. Bevan Reversal of Endothelin-1 Release by Stimulation of Endothelial {alpha}2-Adrenoceptor Contributes to Cerebral Vasorelaxation Hypertension, October 1, 1997; 30(4): 830 - 836. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
